Cabot stock performance snapshot

Cabot (CBT) has drawn investor attention after posting annual revenue of US$3.6b and net income of US$306.0m, alongside mixed total return figures that range from a slight 1 year decline to multi year gains.

The share price has gathered some positive momentum recently, with a 7 day share price return of 3.25% and a year to date share price return of 14.62%. This comes even though the 1 year total shareholder return is slightly negative, while multi year total shareholder returns remain firmly positive.

If Cabot has caught your eye, it can be useful to see what else is moving in materials and related sectors by scanning 8 top copper producer stocks.

With Cabot trading close to analyst targets yet screening on some measures as intrinsically discounted, the key question for you is simple: is there still an opportunity here, or is the market already pricing in future growth?

Price-to-Earnings of 13.1x: Is it justified?

At a last close of $76.85, Cabot is flagged as good value with a P/E of 13.1x compared both to the US Chemicals industry average of 29.8x and a peer average of 21.6x. This points to the market pricing its earnings more cautiously than many competitors.

The P/E ratio compares what you pay per share to the company’s earnings per share, so it is a quick way to see how the market values current profits. For a mature, profitable chemicals business that reports high quality earnings and has become profitable over the past 5 years, a materially lower P/E than sector and peer benchmarks suggests investors are either assigning a discount to its earnings profile or are more optimistic about others in the group.

Against that backdrop, Cabot is also assessed as trading at 20.9% below an estimate of its fair value and at a discount to an SWS DCF model fair value of $97.15, compared with the current $76.85 share price. In other words, the current earnings multiple sits well below both sector averages and internal fair value work, which indicates the valuation level could shift if sentiment toward its earnings strength changes.

Result: Price-to-earnings of 13.1x (UNDERVALUED)

However, you also need to weigh catalysts that could cap any re rating, such as the slight 1 year total return decline and the fact that Cabot is trading close to analyst targets.

Another view on Cabot's value

The earlier P/E work suggests Cabot is on the cheap side, but our SWS DCF model paints a similar picture in a different way. On this approach, the estimated future cash flow value sits at $97.15 per share versus the current $76.85 price, which implies the stock screens as undervalued on cash flows as well as earnings. The open question for you is whether Cabot's cash generation really lines up with that higher estimate or if the market is pricing in risks that this model does not fully capture.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Cabot for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 56 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Given the mixed signals so far, the real question is what the numbers mean to you right now. Take a closer look at the data, stress test your own thesis, and weigh both the upside and the downside by checking 2 key rewards and 1 important warning sign.

Looking for more investment ideas?

If Cabot feels interesting but you want a fuller watchlist, use the screeners below to spot other clear, data backed ideas before the crowd notices.

• Target value focused opportunities by sorting companies that combine quality with attractive pricing using the 56 high quality undervalued stocks.
• Prioritise resilience by filtering for companies that pass strict balance sheet and fundamentals checks with the solid balance sheet and fundamentals stocks screener (42 results).
• Hunt for potential under the radar winners by scanning the screener containing 24 high quality undiscovered gems and seeing which names stand out to you.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.